glp-1 alcohol abuse IUPHAR review – Glucagon-like peptide-1 (GLP-1) and substance use disorders: An emerging pharmacotherapeutic target GLP-1s Hold Promise as Treatment

Whatever your situation, whether you are an athlete pushing your limits, someone who suffers from chronic pain, or just someone who wants to live an active life, BPC-157 offers a promising solution

Jones KL, Rigda RS, Buttfield MDM et al (2019) Effects of lixisenatide on postprandial blood pressure, gastric emptying and glycaemia in healthy people and people with type 2 diabetes

Oligodendroglial NMDA receptors regulate glucose import and axonal energy metabolism

Bursas in the foot can become inflamed and painful due to excessive walking, running, or jumping

Bupropion (Zyban) is licensed in the UK for smoking cessation, whilst Saxenda (liraglutide) is a GLP-1 receptor agonist approved for weight management in adults with obesity or overweight with comorbidities

Further, it upregulates multiple growth receptors in the body and stimulates the production of fibroblasts, vital to the synthesis of collagen